Cubist Systematic Strategies, LLC - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217125. A total of 57 filers reported holding BIOPLUS ACQUISITION CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q3 2023$14,083
-63.3%
251,483
-3.5%
0.00%
Q2 2023$38,395
+49.9%
260,483
-3.4%
0.00%
Q1 2023$25,620
-4.9%
269,6830.0%0.00%
Q4 2022$26,941
+22.5%
269,6830.0%0.00%
Q3 2022$22,000
-42.1%
269,6830.0%0.00%
Q2 2022$38,000
-38.7%
269,6830.0%0.00%
-100.0%
Q1 2022$62,000269,6830.00%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 200,049$1,976,0000.04%
Q Global Advisors, LLC 195,694$45,0000.03%
Telemetry Investments, L.L.C. 33,303$7,0000.01%
FIFTH LANE CAPITAL, LP 51,250$12,0000.01%
MARSHALL WACE, LLP 190,150$1,879,0000.00%
CANTOR FITZGERALD, L. P. 250,000$58,0000.00%
MMCAP International Inc. SPC 325,000$75,0000.00%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 650,866$150,0000.00%
Context Capital Management, LLC 105,069$24,0000.00%
COWEN AND COMPANY, LLC 94,785$22,0000.00%
View complete list of BIOPLUS ACQUISITION CORP shareholders